GlassScriptPhysician profile
Yeon J Park
NPI 1538507199
$3,308.42
in general payments reported to CMS, 2019-2025
31 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $724 · 2020: $221 · 2021: $919 · 2022: $448 · 2023: $393 · 2024: $308 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $957.21 | 2019-2023 | |
| Applied Medical Resources Corporation | $445.89 | 2019 | |
| Astellas Pharma US INC | $277.75 | 2019-2025 | Veozah |
| Shield Therapeutics INC | $196.11 | 2022-2025 | Accrufer |
| Mayne Pharma Commercial LLC | $191.92 | 2021-2025 | |
| Evofem Biosciences, INC. | $144.29 | 2021-2025 | Phexxi, Solosec, Phexx |
| Myovant Sciences INC. | $99.12 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $86.36 | 2023-2025 | Myfembree |
| Agile Therapeutics, INC. | $85.02 | 2021-2022 | |
| Hologic Sales and Service, LLC | $83.98 | 2021-2024 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $74.95 | 2019-2020 | |
| Therapeuticsmd, INC. | $73.01 | 2019-2021 | |
| Optumhealth Care Solutions, LLC | $70.04 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Merck Sharp & Dohme LLC | $49.57 | 2021-2024 | Gardasil 9, Gardasil |
| Aspira Women'S Health INC | $43.43 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $41.62 | 2022 | |
| Millicent US INC | $39.86 | 2020-2024 | Intrarosa |
| Davol INC. | $38.98 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $38.29 | 2021 | |
| Exeltis, USA INC. | $33.55 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $31.94 | 2024 | Spravato |
| Avion Pharmaceuticals | $25.26 | 2020-2022 | |
| Lupin INC. | $25.15 | 2020-2021 | |
| Biogen, INC. | $23.88 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $23.47 | 2025 | Cologuard Collection Kit |
| Solventum Corporation | $22.91 | 2025 | Prevena |
| Duchesnay USA Incorporated | $20.93 | 2019 | |
| Convatec INC. | $20.30 | 2023 | |
| Coopersurgical, INC. | $15.81 | 2021 | |
| Lilly USA, LLC | $15.18 | 2020 | |
| Allergan, INC. | $12.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yeon Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.